BeneFIX Works
BeneFIX has been proven effective in several important clinical trials. In some studies, BeneFIX was tested for its ability to bleeds, and in others, for its ability to bleeds once they started. The results add up to treatment that may work for you. Talk to your doctor about which Factor IX product may be right for you.
BeneFIX prevented bleeds
An important clinical study showed that BeneFIX prevented bleeds in many
previously untreated patients (PUPs):
- 27 of 32 PUPs experienced no spontaneous bleeding (bleeding not caused by injury) within 48 hours of infusion with BeneFIX
- 84.3% of PUPs experienced no spontaneous bleeds and 15.6% of PUPs experienced spontaneous bleeds
- BeneFIX received a 97.7% excellent or effective response rating by patients in the study
- 91.3% of patients rated their infusion response as excellent; 6.4% rated it as effective; 1.7% rated it as inadequate; and 0.6% didn’t rate it
- Study design: 24 PUPs were administered BeneFIX at least twice weekly. Eight PUPs were administered BeneFIX once weekly. The mean dose per infusion was 73.3 ± 33.1 IU/kg, and the mean duration of treatment was 14.4 ± 8.1 months
BeneFIX controlled bleeds
A separate study also examined how BeneFIX controlled spontaneous bleeding or bleeding caused by injury in previously treated patients (PTPs):
- Among 55 PTPs with bleeding episodes, all 1,796 bleeds were controlled
- — 90.9% of responses to first infusion for bleeding episodes were rated excellent or good
- — 7.1% were rated moderate
- — 0.7% were rated no response
- — 1.3% were not rated
- 1 infusion of BeneFIX was needed to control most (81%) bleeds
- Study design: 56 PTPs were treated for bleeding episodes. The mean duration of treatment was 23.4 ± 5.3 months. The regimen was prescribed by the investigator
BeneFIX is also approved for the control and prevention of bleeding in patients undergoing surgery
- Talk to your doctor if you plan to have surgery